β-Arrestin1 enhances hepatocellular carcinogenesis through inflammation-mediated Akt signalling

Nature Communications

Volumn 6, Issue , 2015, Pages

  Yang, Yidong ^a,b   Guo, Yunwei ^a,b   Tan, Siwei ^a,b   Ke, Bilun ^a,b   Tao, Jin ^a,b   Liu, Huiling ^a,b   Jiang, Jie ^a,b   Chen, Jianning ^a   Chen, Guihua ^a,b   Wu, Bin ^a,b  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Provincial Key Laboratory of Liver Disease Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN 1; DIETHYLNITROSAMINE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; ALKYLATING AGENT; BETA ARRESTIN; MESSENGER RNA; RETINA S ANTIGEN; TUMOR NECROSIS FACTOR;

CARCINOGEN; CELLS AND CELL COMPONENTS; GENE EXPRESSION; GENOTOXICITY; ORGANIC NITROGEN COMPOUND; PROTEIN; RODENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME BINDING; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HEPATITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION; ANIMAL; CANCER TRANSPLANTATION; CARCINOGENESIS; CHEMICALLY INDUCED; DRUG EFFECTS; EXPERIMENTAL LIVER NEOPLASM; GENETICS; HEPG2 CELL LINE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KNOCKOUT MOUSE; LIVER TUMOR; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

MUS;

ALKYLATING AGENTS; ANIMALS; ARRESTINS; BLOTTING, WESTERN; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DIETHYLNITROSAMINE; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIVER NEOPLASMS; LIVER NEOPLASMS, EXPERIMENTAL; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84935851247     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8369     Document Type: Article

References (42)

1. Forner, A., Llovet, J. M. & Bruix, J. Hepatocellular carcinoma. Lancet 379, 1245-1255 (2012).
2. Park, E. J. et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197-208 (2010).
3. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
4. El-Serag, H. B. & Rudolph, K. L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132, 2557-2576 (2007).
5. Sun, B. & Karin, M. Obesity, inflammation, and liver cancer. J. Hepatol. 56, 704-713 (2012).
6. He, G. et al. Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384-396 (2013).
7. Fujiki, H., Sueoka, E. & Suganuma, M. Tumor promoters: from chemicals to inflammatory proteins. J. Cancer Res. Clin. Oncol. 139, 1603-1614 (2013).
8. Hatano, E. Tumor necrosis factor signaling in hepatocyte apoptosis. J. Gastroenterol. Hepatol. 22(Suppl 1): S43-S44 (2007).
9. Xia, L. et al. The TNF-alpha/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis 33, 2250-2259 (2012).
10. Yan, J. et al. Inactivation of BAD by IKK inhibits TNFalpha-induced apoptosis independently of NF-kappaB activation. Cell 152, 304-315 (2013).
11. Hatano, E. & Brenner, D. A. Akt protects mouse hepatocytes from TNF-alphaand Fas-mediated apoptosis through NK-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1357-G1368 (2001).
12. Ozes, O. N. et al. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1. Proc. Natl Acad. Sci. USA 98, 4640-4645 (2001).
13. Chan, C. H. et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 149, 1098-1111 (2012).
14. Calvisi, D. F. et al. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma. Gastroenterology 140, 1071-1083 (2011).
15. Ho, C. et al. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/SKP2, and c-Myc pathways. Hepatology 55, 833-845 (2012).
16. Cuconati, A. et al. Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells. PLoS ONE 8, e54595 (2013).
17. Rockman, H. A. & Lefkowitz, R. J. Introduction to the series on novel aspects of cardiovascular G-protein-coupled receptor signaling. Circ. Res. 109, 202-204 (2011).
18. Chen, W. T. et al. GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN. Oncogene 42, 4997-5005 (2013).
19. Whalen, E. J., Rajagopal, S. & Lefkowitz, R.J. Therapeutic potential of b-arrestin- and G protein-biased agonists. Trends Mol. Med. 17, 126-139 (2011).
20. Khoa, N. D., Postow, M., Danielsson, J. & Cronstein, B. N. Tumor necrosis factor-alpha prevents desensitization of Galphas-coupled receptors by regulating GRK2 association with the plasma membrane. Mol. Pharmacol. 69, 1311-1319 (2006).
21. Lattin, J. et al. G-protein-coupled receptor expression, function, and signaling in macrophages. J. Leukoc. Biol. 82, 16-32 (2007).
22. Chen, J. et al. Association analysis between SNPs in IL-28B gene and the progress of hepatitis B infection in Han Chinese. PLoS ONE 7, e50787 (2012).
23. Hu, S. et al. Involvement of beta-arrestins in cancer progression. Mol. Biol. Rep. 40, 1065-1071 (2013).
24. Zou, L., Yang, R., Chai, J. & Pei, G. Rapid xenograft tumor progression in betaarrestin1 transgenic mice due to enhanced tumor angiogenesis. FASEB J. 22, 355-364 (2008).
25. DeWire, S. M., Ahn, S., Lefkowitz, R. J. & Shenoy, S. K. Beta-arrestins and cell signaling. Annu. Rev. Physiol. 69, 483-510 (2007).
26. Schulte, G. & Shenoy, S. K. beta-Arrestin and dishevelled coordinate biased signaling. Proc. Natl Acad. Sci. USA 108, 19839-10840 (2011).
27. Qiu, W. et al. PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology 54, 1249-1258 (2011).
28. Hara, M. R. et al. A stress response pathway regulates DNA damage through beta2-adrenoreceptors and beta-arrestin-1. Nature 477, 349-353 (2011).
29. Budhu, A. & Wang, X. W. The role of cytokines in hepatocellular carcinoma. J. Leukoc. Biol. 80, 1197-1213 (2006).
30. Kassardjian, A., Dakroub, Z., Zein, O. E. & Kreydiyyeh, S. I. Signaling pathway underlying the up-regulatory effect of TNF-alpha on the Na(+)/K(+) ATPase in HepG2 cells. Cytokine 49, 312-318 (2010).
31. Lin, W. W. & Karin, M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J. Clin. Invest. 117, 1175-1183 (2007).
32. Diao, Y., Zhao, X. F., Lin, J. S., Wang, Q. Z. & Xu, R. A. Protection of the liver against CCl4-induced injury by intramuscular electrotransfer of a kallistatin-encoding plasmid. World J. Gastroenterol. 17, 111-117 (2011).
33. Storlazzi, C. T. et al. Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma. Leukemia 21, 2221-2225 (2007).
34. Kai, H. et al. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma. Pathol. Res. Pract. 15, 43-48 (2011).
35. Hooks, S. B. et al. Regulators of G-Protein signaling RGS10 and RGS17 regulate chemoresistance in ovarian cancer cells. Mol. Cancer 9, 289 (2010).
36. Sobolesky, P. M. & Moussa, O. The role of beta-arrestins in cancer. Prog. Mol. Biol. Transl. Sci. 118, 395-411 (2013).
37. Bonnans, C. et al. Essential requirement for beta-arrestin2 in mouse intestinal tumors with elevated Wnt signaling. Proc. Natl Acad. Sci. USA 109, 3047-3052 (2012).
38. Pillai, S. et al. beta-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition. Cancer Res. 75, 1009-1020 (2015).
39. Yang, Q. et al. Tumor necrosis factor-alpha mediates JNK activation response to intestinal ischemia-reperfusion injury. World J. Gastroenterol. 19, 4925-4934 (2013).
40. Kovacs, J. J., Hara, M. R., Davenport, C. L., Kim, J. & Lefkowitz, R. J. Arrestin development: emerging roles for beta-arrestins in developmental signaling pathways. Dev. Cell 17, 443-458 (2009).
41. Nakanishi, K., Sakamoto, M., Yamasaki, S., Todo, S. & Hirohashi, S. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma. Cancer 103, 307-312 (2005).
42. Shi, Y. et al. Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat. Immunol. 8, 817-824 (2007).